This inventor holds 4 USPTO granted patents and 4 published patent applications and 4 EPO patents. Top assignee: Neurocrine Biosciences, Inc.. Active years: 2021-2026.
Company Filing History:
Years Active: 2021-2026
Title: Innovations of Inventor Nicholas Pagano
Introduction
Nicholas Pagano is a notable inventor based in San Diego, CA. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target specific receptors in the human body. With a total of 4 patents to his name, Pagano's work is paving the way for new treatments for various diseases.
Latest Patents
One of his latest patents is focused on muscarinic receptor 4 antagonists and methods of use. This patent provides compounds of a specific formula and outlines methods for treating diseases, disorders, or symptoms by antagonizing muscarinic receptors, particularly the M4 receptor. Another significant patent involves substituted pyrido[2,1-a]isoquinolines as VMAT2 inhibitors. This disclosure relates to VMAT2 inhibitor compounds and their pharmaceutically acceptable salts, along with related compositions and methods.
Career Highlights
Nicholas Pagano is currently employed at Neurocrine Biosciences, Inc., where he continues to innovate and develop new pharmaceutical solutions. His work is instrumental in advancing the understanding and treatment of various neurological conditions.
Collaborations
Throughout his career, Pagano has collaborated with talented individuals such as Nicole Harriott and Scott Stirn. These partnerships have contributed to the successful development of his patented inventions.
Conclusion
Nicholas Pagano's contributions to the field of pharmaceuticals through his innovative patents demonstrate his commitment to advancing medical science. His work continues to inspire future developments in the treatment of neurological disorders.